Non-coding RNAs in Endocrinology
Ed. by Hardikar, Anandwardhan
1 Issue per year
Non-coding RNAs in Endocrinology (ncRNAs Endocrinol) is the world's first peer-reviewed specialty journal in this emerging area of biology. The journal presents technological advances in the field on the basis of their novelty, importance to other researchers, elegance and surprising conclusions. The journal offers a continuous publication platform, which means no more waiting for articles to be allocated to specific issues. The category of articles that are published range from but are not limited to original research, reviews, perspectives / commentaries on other published research, methodologies, images in ncRNA world as well as commercial technological reports. The Journal Editor is committed to prompt publication of significant advances in this area of biology and to provide a forum for reporting and discussing your views.
Aims and Scope
Why subscribe and read
Non-coding RNAs in Endocrinology (ncRNAs Endocrinol) is the world's first peer-reviewed specialty journal in this emerging area of biology. The journal presents technological advances in ncRNA discoveries with specific reference to diabetes, obesity and cardiovascular complications as well as other areas of endocrine biology. Articles are chosen on the basis of their novelty, importance to other researchers, elegance and surprising conclusions. The journal offers a continuous publication platform, which means no more waiting for articles to be allocated to specific issues. The category of articles that are published range from but are not limited to original research, reviews, perspectives / commentaries on other published research, methodologies, images in ncRNA world as well as commercial technological reports. The Journal Editor is committed to prompt publication of significant advances in this area of biology and to provide a forum for reporting and discussing your views.
Non-coding RNAs in Endocrinology is a first specialty journal presenting interesting and notable findings from non-coding RNA biology in endocrine disease. Although the major focus of the journal will be to present research and views on ncRNAs in adiposity, diabetes and its complications, the journal also welcomes articles presenting the role of ncRNAs in other endocrine diseases. Considering the increasing prevalence of diabetes and obesity all over the world, this is an apt addition to the scientific community. The journal editors are committed to transparent, comprehensive and rapid reviewing of manuscripts. Excellent editorial staff support provides the opportunity to all authors for a fast review process wherein the first response would be generally between 2 to 4 weeks of submission. All manuscripts are submitted online through the manuscript submission system and are guaranteed immediate attention. All accepted manuscripts are corrected for language suitability by our highly trained language editors.
Lastly, the journal offers a unique publishing concept that there are no journal issues. This means less waiting time for accepted articles from being allocated to specific issues.
All of this presents ncRNAs Endocrinol as a unique platform for authors to submit, publish and share their work to the scientific community.
- Type of Publication:
- Researchers in the field of biology.
Submission of Manuscripts
Instructions for Authors
Manuscripts should be submitted to the journal via online submission system Editorial Manager available for this journal at http://mrdo.edmgr.com/. In case of problems, please contact the Journal Editor at email@example.com.
Authors are suggested to follow Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journal Editors (ICMJE).
Manuscript submitted to this journal should:
- contain original work - not published elsewhere in any medium (in the whole or in part) by the authors or anyone else and not under consideration for publication in any other medium;
- focus on the aims and scope of the journal;
- be clearly and correctly written - should contain all essential features of a scientific publication that is easy to understand for the target audience;
- written in English - attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper;
- be delivered in electronic format.
The journal accepts the following publication formats:
- Research Articles
- Communications and Rapid Communications
- Reviews and Mini-Reviews
- Letters to the Editor and Amendments
It is important that authors include a cover letter with their manuscript. Please explain why you consider your manuscript as suitable for publication in the journal, why will your paper inspire the other members of your field, and how will it drive research forward.
The letter should contain all important details such as:
- your full name (submitted by)
- full title of article and short title
- full list of authors with affiliations
- e-mail of the corresponding author
- contact address, telephone/fax numbers of the corresponding author
- number of attached files, if there is more than one
- status: new, reviewed or accepted (with reference ID if reviewed or accepted)
Cover letter should explicitly state that the manuscript (or one with substantially the same content, by any of the authors) has not been previously published in any language anywhere and that it is not under simultaneous consideration or in press by another journal. If related work has been submitted, then we may require a preprint to be made available. Reviewers will be asked to comment on the overlap between the related submissions.
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided.
Conflict of interest declaration
To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Journal Editor.
Open Access License
Authors have to sign an Open Access License that is available on the journal webpage. We encourage the authors to send the signed license along with the manuscript. Please note, that no article will be published unless the Open Access License is signed.
We accept submission of text, tables and figures as separate files or as a composite file. For your initial submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures.
- Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below)
- Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, see below). Please note that a straight Excel file is not an acceptable format
- Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. Please note that Powerpoint files are not accepted
Post acceptance, text files of the revised manuscript and tables are required for use in the production.
Authors should clearly indicate location of tables and figures in the text if these elements are given separately or at the end of the manuscript. If this information is not provided to the editorial office, we will assume that they should be left at the end of the text.
For further instructions, please carefully follow the guidelines described in Instructions for Authors.
Abstracting & Indexing
Non-coding RNAs in Endocrinology is covered by the following services:
- Baidu Scholar
- CNKI Scholar (China National Knowledge Infrastructure)
- EBSCO (relevant databases)
- EBSCO Discovery Service
- Genamics JournalSeek
- Google Scholar
- KESLI-NDSL (Korean National Discovery for Science Leaders)
- Microsoft Academic
- Naviga (Softweco)
- Polish Scientific Journals Database
- Primo Central (ExLibris)
- ProQuest (relevant databases)
- Summon (Serials Solutions/ProQuest)
- Ulrich's Periodicals Directory/ulrichsweb
- WanFang Data
- WorldCat (OCLC)
Anandwardhan A. Hardikar, The University of Sydney, Sydney, Australia
Praveen Sethupathy, UNC Chapel Hill, USA
Xiaoqing Tang, Michigan Technological University, USA
Editorial Advisory Board
Subrata Chakrabarti, University of Western Ontario, Canada
Mark Chong, Walter and Eliza Hall Institute Biotechnology Centre, Australia
Mark Cooper, Baker IDI Heart and Diabetes Institute, Australia
Maria Craig, University of New South Wales, Australia
Costanza Emanueli, University of Bristol, Great Britain
Alicia Jenkins, University of Oklahoma, USA
Philip Kantharidis, Baker IDI Heart and Diabetes Institute, Australia
Ullas Kolthur, Tata Institute of Fundamental Research, India
Francis C. Lynn, University of British Columbia, Canada
Kasey C. Vickers, National Heart, Lung and Blood Institute, NIH, USA
Michael Walker, Weizmann Institute, Israel
Mugdha Joglekar, University of Sydney, Australia
Sarang Satoor, NHMRC Clinical Trials Centre, University of Sydney, Australia
Michael Williams, University of Melbourne, Australia
Pete Campbell, St. Vincent’s Institute of Medical Research, Australia
Ryan Farr, University of Sydney, Australia
Caroline Taylor, O’Brien Institute, Australia
DE GRUYTER Poland
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15